EXR
51
-4
MAS
51
-7
STT
60
-5
CNP
42
-2
K
36
-2
LMT
57
5
MLM
38
-6
FOX
40
-2
NVDA
57
-4
HAS
58
-2
EMR
50
-3
GRMN
49
-9
HST
22
-5
SWK
39
-6
AIG
54
-5
NEM
64
3
EA
50
-2
MO
53
-3
D
38
-7
ZBH
48
-6
EXR
51
-4
MAS
51
-7
STT
60
-5
CNP
42
-2
K
36
-2
LMT
57
5
MLM
38
-6
FOX
40
-2
NVDA
57
-4
HAS
58
-2
EMR
50
-3
GRMN
49
-9
HST
22
-5
SWK
39
-6
AIG
54
-5
NEM
64
3
EA
50
-2
MO
53
-3
D
38
-7
ZBH
48
-6
Financhill
Back

Dyne Therapeutics 10K Form

Sell
49

DYN
Dyne Therapeutics

Last Price:
$14.42
Seasonality Move:
37.52%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive DYN News And Ratings

See the #1 stock for the next 7 days that we like better than DYN

DYN Financial Statistics

Sales & Book Value

Annual Sales: $4.8B
Cash Flow: $-106.9M
Price / Cash Flow: 0
Annual Sales: $5.89
Price / Book: 2.45

Profitability

EPS (TTM): -3.59000
Net Income (TTM): $-367.1M
Gross Margin: $1.9B
Return on Equity: 0%
Return on Assets: 0%

Dyne Therapeutics Earnings Forecast

Key Dyne Therapeutics Financial Ratios

  • The Gross Profit Margin over the past 13 years for DYN is 39.45%.
  • The Selling, General & Administrative Expenses for DYN have been equal to 3.90% of Gross Profit Margin.
  • Per Share Earnings over the last 20 years have been positive in 9 years.

Dyne Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: DYN
CUSIP: 26818M
Website: dyne-tx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

DYN Technical Analysis vs Fundamental Analysis

Sell
49
Dyne Therapeutics (DYN) is a Sell

Is Dyne Therapeutics a Buy or a Sell?

  • Dyne Therapeutics stock is rated a Sell
    The current Dyne Therapeutics [DYN] share price is $14.41. The Score for DYN is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.